In Vitro Antimicrobial Screening of Benzoylthioureas: Synthesis, Antibacterial Activity toward Streptococcus agalactiae and Molecular Docking Study
Authors:
- 8 September 2022
- journal article
- research article
- Published by Wiley in ChemistrySelect
- Vol. 7 (34)
Abstract
Herein, twenty‐six benzoylthioureas were evaluated for their antimicrobial activity against different bacterial and fungal species. Two 4‐substituted benzoylthiourea, one benzoylurea and one benzoylguanidine derivatives were further synthesized to identify the most promising compound. Eight compounds were active against at least one microbial species tested. N ‐(butylcarbamothioyl)‐benzamide ( 1 e ) exhibited the best antimicrobial activity towards Streptococcus agalactiae (group B Streptococcus ‐GBS), including clinical isolates susceptible or resistant to clindamycin and/or erythromycin and azithromycin. 1 e presented a bacteriostatic effect, causing morphological and ultrastructural alterations on planktonic cells, and decreased the metabolic activity of GBS biofilms. No hemolytic and cytotoxicity to mammalian cells were detected for 1 e , that also displayed drug‐likeness properties. Molecular docking was performed on Streptococcus pneumoniae enoyl‐ACP reductase obtained by homology modeling. 1 e showed relevant interactions with the GBS enoyl‐ACP reductase enzyme. N ‐(butylcarbamothioyl)‐benzamide may be a good starting point for the development of new antimicrobials against GBS.Keywords
This publication has 56 references indexed in Scilit:
- Commensal Streptococcus agalactiaeisolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinantsBMC Microbiology, 2013
- Avogadro: an advanced semantic chemical editor, visualization, and analysis platformJournal of Cheminformatics, 2012
- Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug DiscoveryACS Chemical Neuroscience, 2011
- Crystal structure of enoyl–acyl carrier protein reductase (FabK) from Streptococcus pneumoniae reveals the binding mode of an inhibitorProtein Science, 2008
- SWISS-MODEL: an automated protein homology-modeling serverNucleic Acids Research, 2003
- Mechanistic diversity and regulation of Type II fatty acid synthesisBiochemical Society Transactions, 2002
- T-coffee: a novel method for fast and accurate multiple sequence alignment 1 1Edited by J. ThorntonJournal of Molecular Biology, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Regulation of Fatty Acid Elongation and Initiation by Acyl-Acyl Carrier Protein in Escherichia coliJournal of Biological Chemistry, 1996
- Assessment of protein models with three-dimensional profilesNature, 1992